MIRA
INFORM REPORT
|
Report Date : |
22.08.2008 |
IDENTIFICATION
DETAILS
|
Name : |
YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD |
|
|
|
|
Registered Office : |
1191 Chungshan Rd Section 1 Tachia Chen Taichung Hsien 437 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Financial as on : |
2007 |
|
|
|
|
Date of Incorporation : |
26.08.1965 |
|
|
|
|
Com. Reg. No.: |
56065601 |
|
|
|
|
Legal Form : |
Public Listed Company |
|
|
|
|
Line of Business : |
Research and Development of Pharmaceutical Products, Cosmetics and
other related products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Aa |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
Maximum Credit Limit : |
USD 5,000,000 |
|
|
|
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
name & address
YUNG
SHIN PHARMACEUTICAL INDUSTRY CO LTD
1191 CHUNGSHAN RD SECTION 1
TACHIA CHEN TAICHUNG HSIEN 437, TAIWAN
TEL: 886-4-26875100 FAX:
886-4-26869418
EXECUTIVE SUMMARY
INCORPORATION DATE : AUGUST 26, 1965
REGISTRATION NO. :
56065601
LEGAL FORM :
PUBLIC LISTED COMPANY
CHIEF EXECUTIVE :
DR. FANG-CHUAN LEE (CEO)
STAFF STRENGTH :
1,164
CAPITAL :
US$ 101,806,240
BUSINESS LINE : MANUFACTURER
TURNOVER :
NTD 3,128,157,000 (AS OF 2007)
EQUITIES :
NTD 5,163,350,000 (AS OF 2007)
PAYMENT :
EXCELLENT
RECOMM. CREDIT RANGE : UP TO
USD 5,000,000
MARKET CONDITION :
COMPETITIVE
FINANCIAL CONDITION : FAIRLY GOOD
OPERATIONAL TREND : STEADY
GENERAL REPUTATION : WELL KNOWN
EXCHANGE RATE :
TWD 31.39819 = US$1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
TWD –Taiwan New Dollars
*Company Name*
=============
Founded as :
YUNG SHIN DRUGSTORE
Year founded : 1952
Change name to : YUNG
SHIN PHARMACEUTICAL INDUSTRIAL CO LTD
Date of change : 26
August, 1965
*Company History*
===============
1952 -
Founded as a family-owned drug store, primarily engaged in the wholesale and
retail distribution of European and American pharmaceutical products.
1966 -
Rated as “Class A Comprehensive Pharmaceutical Co" by the Health Authority
1969 -
Established Taipei Service Center
1974 -
Established Kaohsiung Service Center
- Introduced injectible products to the market
- Established ANGEL ASSOCIATES (TAIWAN) INC to handle import and export
of bulk pharmaceutical products and raw materials
1975 -
Established Yung Shin Recreational Park
1978 - Established Yung Shin Social Welfare
Foundation
- Established YUNG ZIP CHEMICAL INDUSTRY CO LTD to ensure adequate
supply of bulk pharmaceutical materials
1981 -
Established YSP Information Center to enhance the management system and improve
the efficiency and quality of overall information operation
1982 -
Established Bioavailability Laboratory (BA Lab)
1985 -
Established YUNG SHIN CO LTD in Hong Kong to directly market pharmaceutical
products to the world
1986 -
Expanded the scope of its R&D Division
- Completed GMP Manufacturing Facility
1988 -
Invested in the foundation of YSP INDUSTRIES (M) SDN BHD
1989 -
Entered agency contact with SALTERS-FISHER MEDICAL HOLDINGS LTD (South Africa)
1990 - Established
its first wholly-owned subsidiary, YSP INDUSTRIES (M) SDN BHD after two years
of market survey.
- Expanded its business to the USA by establishing CARLSBAD TECHNOLOGY
INC
- Established another subsidiary in Singapore, YUNG SHIN PHARMACEUTICAL
(S) PTE LTD
January 1993 -
Approved by the Securities & Futures Commission (SFC) as " first-tier
stocks"
3 May, 1993 - Became
a public listed company under the Taiwan Stock Exchange (TSE)
1994 -
Became the first Taiwan-based pharmaceutical company to successfully penetrate
the traditional closed Japanese market by marketing Cimetidine tablet and
Piperacillin injectable
- Established SHANGHAI YUNG ZIP
PHARMACEUTICAL TRADING CO LTD and YUNG SHIN PHARMACEUTICAL INDUSTRIAL (KS) CO
LTD, both in China
July 1994 -
Launched its unique product line APPAS cosmetics, qualified for marketing in
Japan by the Japanese Ministry of Health, Labor and Welfare.
December 1994 - Initiated
Seasoned Equity Offering (SEO) of NTD200 million, in order to implement a
series of development projects
1997 -
Introduced functional food and Chinese herbal product.
- Established fermentation plant, food plant, diagnostic regeant palnt
and automatic warehousing facilities
1998 -
Contributed 0.2% of its annual revenue into the government Drug Injury Relief
Program, which is used to protect consumers' rights and defend faultless
vendors
- Established BIO TRUST INT'L CORP
1999 -
Invested a total of NTD 300 million for the construction of a new facility of
antibiotics production plant
2001 -
Completed Yung Shin Elder Nursing Home for senior citizens.
- Started production of Paclitaxel injectable and the product became
available in the market as a drug covered by NHI reimbursement.
2003 -
Introduced Carlsbad Beauty foods.
2004 -
Got the FDA Confirmation of American on the facility of cephalosporin, lovastatin and cephaclor
capsule products.
- Fang-yu Lee, President replaced the Chairman
1 January, 2004 - YSP SAH
issued the certificate of stock
March, 2005 - YSP and
Chung Shan Medical University signed a treaty establishment "Te-Tien of
YSP Medicine Course".
November, 2005 - Fang-chuan
Lee, Chairman of YUNG ZIP CHEMICAL, took over YSP Chairman of the Board.
2007 -
FDA approved generic versions of Zolpidem tartrate immediate-release tablets
- FDA approved generic versions of Cephalexin for Oral Suspension USP
*Licenses & Permits*
=================
(1)
License number : 9963318000
Date issued : 21 November, 1984
Issuing authority :
Industrial Development Bureau, MOEA
Type of license : Factory license
(2)
License number : 9963316200
Date issued : 11 January, 1979
Issuing authority :
Industrial Development Bureau, MOEA
Type of license : Factory license
(3)
License number : 9963316301
Date issued : 4 May, 1998
Issuing authority :
Industrial Development Bureau, MOEA
Type of license : Factory license
(4)
License number : 9963316100
Date issued :
27 January, 1996
Issuing authority :
Industrial Development Bureau, MOEA
Type of license : Factory license
*Capital Details*
=============
Authorized capital : NTD 3,100,000,000.00
Initial paid-up capital : NTD
1,500,000.00
Paid-up capital increases as follows:
Year
Increase (NTD)
------
--------------------
1966
2,000,000.00
1974
14,000,000.00
1976 21,000,000.00
1981
62,000,000.00
1984
98,000,000.00
1985
170,000,000.00
1986
190,000,000.00
1988
235,000,000.00
1989 360,000,000.00
1990
500,000,000.00
1991
700,000,000.00
1994
1,162,470,000.00
1998
1,696,977,080.00
1999
2,196,850,000.00
2000 2,416,535,000.00
-
2,537,361,750.00
*Office & Facilities*
================
Building size : 1,940 sq meters (Approx)
Location : Taichung Hsien
Facilities : Modern
Property status : Owned by YUNG SHIN PHARMACEUTICAL
INDUSTRY CO LTD
Type of building : Industrial
building
Comment : Serves as office, factory and
warehouse
Activity : Production of a full range of
products such as pharmaceuticals, veterinary products, food supplements,
Chinese herbal products, cosmetics and diagnostics
Other Contact Details
-----------------------------
Tel no. : 4-26813671
Fax nos. : 4-26704962 / 26813672
E-mail : gbcd@yungshingroup.com
Website : www.yungshingroup.com
Previous Contact Details
---------------------------------
Address : 8Fl, 439 Rui Kuang Rd Neihu Dist Taipei City 114
Tel no. : 2-87978351
Fax no. : 2-87978353
*Factories, Size & Locations*
=====================
The firm maintains three (3) manufacturing facilities as listed below :
(1)
License number : 9963316200
Building size : 11,662 sq
meters (Approx)
Location : Tachia
Chen
Facilities : Modern
Property status : Owned by YUNG
SHIN PHARMACEUTICAL INDUSTRY CO LTD
Type of building : Industrial building
(2)
License number : 9963316301
Building size : 6,402 sq
meters (Approx)
Location : Taichung
County
Facilities : Modern
Property status : Owned by YUNG
SHIN PHARMACEUTICAL INDUSTRY CO LTD
Type of building : Industrial building
Activity :
Production of bulk pharmaceuticals for fermentation and special chemicals.
(3)
License number : 9963316100
Building size : 1,4058 sq
meters (Approx)
Location : Taichung
Hsien
Facilities : Modern
Property status : Owned by YUNG
SHIN PHARMACEUTICAL INDUSTRY CO LTD
Type of building : Industrial building
Activity :
Production of antibiotics and penicillins.
*Corporate & Organization Structure*
=============================
A large specialized company operated and managed by an experienced team
of professionals.
Organization and management of the company is divided into the following
sections:
- MIS Department
- Auditing Department
- Accounting Department
- Finance Department
- Purchasing Department
- R&D Division
- Consists of the following
departments:
a. Synthesis Chemistry
Research
b. Formulation Research
c. Analytical Chemistry
Research
d. Biotechnology
Research
e. Regulatory Affairs
- Production Division
- Yung Shin Amusement Center
- Sales Division
- Consists of the
following departments:
a. Marketing
Section: business plans, marketing and product development
b. Invoicing &
Receiving Section: managing invoice and collection of payment
c. Division Office:
assisting department leaders and training of new sales representatives
- Maintains a domestic
sales workforce of about 300 personnel.
- General Service Division
- Strategic planning,
analysis, tracking, summarizing and negotiating
- General affairs
- Purchasing
- Capital and asset
management
- Information analysis
for operation and management
- Social welfare and services
- Human Resource Department
- Subordinated the
General Administration Office of the Company.
- Responsible for
planning, executing and analyzing of HR system.
R&D Division
-------------------
- Currently maintains 93 staff where four have doctorate degree, 15 have
master degree and 32 have bachelor degree
- Has developed a total of 38 new products and obtained three patents in
2000
- Has developed a total of 19 new products in 2001
- Collaborative projects
a. Research and development
of long lasting analgesic pro-drug (1 September, 1993 - 31 August, 1996)
b. Research and development
of preventive medicine for cancers (1 June, 1995 - 31 May, 1998)
- New product development
a. Anti-lipimeic lovastatin
development plant (1 July, 1995 - 30 June, 1998)
b. Immuno-suppresant
Cyclosporin A development plan (1 November, 1996 - 30 June, 1999)
c. Cephalosporin sterile
bulk materials (1 July, 1997 - 30 June, 2000)
d. Long acting Nalbuphine analgesic injection development plan
(1 May, 1999 - 30 April, 2002)
FINANCIAL ORGANIZATION CHART
-----------------------------------------------------
Financial
Resource
Administration Office
|
__________________|______________________________
|
|
External
Internal
Financial
Evaluation Planning for Stock
Right Board of Directors
Affairs Promotion
&Establishing
of Financial Regulation
Establishing Fund Planning Promotion &
Establishing Analyzing Financial
Reports
Financial Standard of Accounting System
Analyzing
Financial Reports
*Industry Ranking*
==============
- Generally regarded as one of the Top 1000 companies in manufacturing
industry of Taiwan.
- Ranked by Forbes Magazines as one of the top T00 potential small and
medium enterprise.
Details of rank as follows:
Year Rank
------ -------
1992 403
2005 1,035
2006 1,073
2007 1,059
*Sales Ranking*
============
Generally regarded as one of the Top 1000 companies in manufacturing
industry in Taiwan in terms of sales.
Details of rank as follows:
Year Rank
------ ------
1998 384
1997 388
1996 376
2000 468
2001 417
2002 515
2007 584
*Accountants*
============
- Certified Public Accountants & Business Advisers
*Auditor*
========
- GRANT THORNTON LOSOON
*Registrar*
=========
- POLARIS SECURITIES CO LTD
*Awards*
========
Received the following awards:
(1)
Award : National
Biotechnological Industrial Development Award
Year : 1994
(2)
Award : 2nd Excellence
Award for Industrial Technology Advancement
Awarded by : Executive Yuan
Date : June 1994
(3)
Award : 2nd Excellence
In Biotechnological Development Award
Year : 1995
(4)
Award : Best and Most
Attractive Company to investors in Small & Medium
Awarded by : Asian Currency Magazine (HK)
Year : 1995
(5)
Award : Gold Quality
Award for Overall Pharmaceutical Companies
Year : 1998
Details : The winner
of 1st National Medical & Pharmaceutical Quality Award
(6)
Award : Gold Quality
Award for Single Pharmaceutical Products
Year : 1998
Details : Its Keto
product brand received the said award
(7)
Award : Excellence
Award for Biotechnological Development Industry
Year : 1999
(8)
Award : Most Admired
Company in Taipei
Awarded by : Common Wealth
Magazine
Year : 1999
(9)
Award : 7th Industrial
Technical Development Award
Awarded by : Ministry of
Economic Affairs (MOEA)
Year : 1999
(10)
Award : Most Admired
Company in Taipei
Awarded by : Common Wealth Magazine
Year : 2000
(11)
Award : National Award of Small and Medium
Enterprise
Awarded by : Small and Medium
Enterprise Administration, MOEA
Year : 2001
(12)
Award : Industrial
Excellence Award
Awarded by : Ministry of
Economic Affairs (MOEA)
Year : 2001
(13)
Award : The Lovastatin
API manufactured by Yung Shin Plant II
Awarded by : FDA
Year : 2002
(14)
Award : FDA Certified
Awarded by : FDA
Date : January
2004
(15)
Award : Pass the third
stage evaluation for cGMP
Date :November 2004
(16)
Award : 2005 top 200
successful enterprises in Asian and Pacific region
Awarded by : Forbes
Date : November
2005
Details : Rated at the
criteria: annual revenue below USD 1 billion, and 5 years ROI above 5%
(17)
Award : FDA ANDA
Awarded by : N/A
Date : July 2007
Details : Approval for
Cephqlexin oral Suspension
(18)
Award : Industrial Excellence
Award
Year : 2007
(19)
Award : National
Sustainable Development Award
Year : 2007
www.ysp.com.tw
this website belongs to “Yung Shin Group”. The design is professional and the
content is well organized. At present it is in both Chinese and English
versions.
E-mail: ysp@mail.ysp.com.tw
For the past two years there is no record of litigation.
*Major Shareholders*
===============
Total number of shareholders: N/A
Total number of shares: N/A
Shareholders Country Number Amount %
Ms. Fang-hsin Lee Taiwan 10,724,602.00 n/a n/a
Dr. Fang-chuan Lee Taiwan 7,448,813.00 n/a n/a
Ms. Ling-chin Lee Taiwan 7,135,145.00 n/a n/a
Mr. Ming-ju Lee Taiwan 4,072,529.00 n/a n/a
Mr. Min-hsiung Lee Taiwan 2,019,600.00 n/a n/a
Mr. Wen-fu Lin Taiwan 1,532,689.00 n/a n/a
Mr. Sheng-hui Lee Taiwan 831,769.00
n/a n/a
Mr. Wei-chen Tang Taiwan 669,454.00
n/a n/a
Mr. Sheng-chu Kuo Taiwan 47,916.00 n/a n/a
Management: Mr. Wei-chen Tang,
Manager
Mr. Ho-ching Huang, Manager
Ms. Shu-yuan Chuang, Manager
Name Nationality
Job Description Dept. / Division
Mr. Wei-chen Tang Taiwanese
Manager Account
Mr. Ho-ching Huang Taiwanese Manager Audit
Ms. Shu-yuan Chuang Taiwanese Manager Audit
Ms. Pei-chun Chen Taiwanese Manager Finance
Mr. Teh-ming Lu Taiwanese
Assist. Manager -
Dr. Fang-chuan Lee Taiwanese
CEO -
Mr. Chih-jen Sung Taiwanese
Manager -
Mr. Kuo-hsiung Hsieh Taiwanese Manager -
Mr. Fang-yu Lee Taiwanese
President -
Mr. Wen-chih Lee Taiwanese
Vice General Manager -
Ms. Ling-chin Lee Taiwanese
Vice General Manager -
*COMPANY DIRECTORS*
=====================
1
Name : Dr. Fang-chuan Lee
Nationality : Taiwanese
2
Name : Mr. Fang-yu Lee
Nationality : Taiwanese
Country of Residence : Taiwan
3
Name : Mr. Shan-chiung Chen
Nationality : Taiwanese
*Main Products & Services*
======================
Specializes in the following areas of work:
1. Research and development of pharmaceutical products, cosmetics and
other related products.
2. Importing of raw materials for in-house OEM and ODM production
3. Manufacturing a wide range of products such as ordyceps sinensis
mycelium, ganoderma lucidum mycelium and other related products.
4. Export and domestic sales of its finished products.
Products also include:
- cordyceps sinensis mycelium
- ganoderma lucidum mycelium
Sales breakdown as per product :
Product Percentage (%)
----------- -------------------
Medicine for human beings 88
Veterinary products 10
Others 2
Products: API
Analgesics
Anti-insect
lotion
Antibiotic
preparations
Antibiotics
*Brand*
======
APPAS
Cety
Fukole
KETO
Soonmelt
Yung Shin
*Payment Terms*
=============
Sales
-------
Local : 30-90 days credit
Export : Letter of Credit (L/C)
Telegraphic
Transfer (T/T)
Purchases
--------------
Local : 30-90 days credit
Import : Letter of Credit (L/C)
Telegraphic
Transfer (T/T)
*Production Capacity*
==================
Year: 2002
1. Human Pharmaceutical
Item Maximum
Capacity Current Capacity
------ ------------------------- -----------------------
Suppository 137,190,000 pcs 10,541,000 pcs
Capsule 987,539,000 pcs 324,575,000 pcs
Pellet 55,211,000
pcs 19,027,000 pcs
Injection 185,569
ltrs 15,626 ltrs
Ointment 145,746 ltrs 37,315 ltrs
Powder 11,967
Kg 5,625 Kg
Sirup 335,767
ltrs 85,806 ltrs
Pastille 1,846,779,000 pcs 788,500,000 pcs
Raw Materials 700 ltrs 82 ltrs
2. Animal Pharmaceutical
Item Maximum
Capacity Current Capacity
------
-------------------------
-----------------------
Injection
250,500 ltrs 451 ltrs
Powder 550,293 ltrs 200,781 ltrs
Sirup 28,785
ltrs 17,404 ltrs
3. Health Foods
Item Maximum
Capacity Current Capacity
------
-------------------------
-----------------------
Capsule 32,011,000 pcs 5,636,000 pcs
Pellet 320,100,000
pcs 3,267,000 pcs
Pastille 90,271,000 pcs 2,836,000 pcs
Year : 2007
1. Human Pharmaceutical
Item Maximum
Capacity Current Capacity
------ ------------------------- -----------------------
Suppository 137,190,000 pcs 12,328,000 pcs
Capsule 987,539,000 pcs 494,829,000 pcs
Pellet 55,211,000 pcs 14,169,000 pcs
Injection 158,569
ltrs 26,757 ltrs
Ointment 145,746 ltrs 63,042 ltrs
Powder 11,967
Kg 6,050 Kg
Sirup 335,767
ltrs 98,476 ltrs
Pastille 1,846,779,000 pcs 1,277,462 pcs
Raw Materials 50,000 ltrs 6,996 ltrs
2. Animal Pharmaceutical
Item Maximum
Capacity Current Capacity
------
-------------------------
-----------------------
Injection 250,500 ltrs 451 ltrs
Powder 550,293
ltrs 235,245 ltrs
Sirup 28,785
ltrs 22,764 ltrs
3. Health Foods
Item Maximum
Capacity Current Capacity
------
-------------------------
-----------------------
Capsule 32,011,000 pcs 23,625,000 pcs
Pellet 320,110,000
pcs 317,000 pcs
Pastille 90,271,000
pcs 24,378,000 pcs
Test reagent 217,000 pcs 101,000 pcs
4. Cosmetics Pharmaceuticals
Item Maximum
Capacity Current Capacity
------
-------------------------
-----------------------
Cream 28,010,000
litre 477,000
litre
Liquid 140,048,000
litre 12,532,000
litre
*Detailed Product Specifications*
==========================
(1)
Product : Antihistamine
FC tablets
Brand : Cety
Applications : For the relief of urticaria, atopic dermatitis itching,
allergic rhinitis, conjunctivitis, and other allergic symptoms.
(2)
Product : Dosing
regimen capsule
Brand : Fukole
Applications : For the treatment
of dermatomycosis (Tinea pedis, Tinea corporis, Tinea cruris, Tinea unguium,
Tinea versicolor), oral candiasis, candida vulvovaginitis, and cyptococcus.
meningitis
(3)
Product : FC tablets
Brand : Soonmelt
Applications : For the treatment of infections caused by susceptible
strains of Staphylococcus, Streptococcus, S. pneumoniae, and Meningococcus.
*Quality Certification*
==================
Obtained the following certifications :
(1)
Type of certification : GMP
Issuing authority : Department
of Health (DOH)
Year of certification : 1986
(2)
Type of certification : Phase I cGMP
Date of certification : 5
February, 2001
Other details :
Obtained by Youth Plant I
(3)
Type of certification : Phase II cGMP
Date of certification : 23
February, 2001
Other details :
Obtained by Youth Plant III
(4)
Type of certification : GMP
Issuing authority : BPA of
DOH
Date of certification : 18 March, 2003
Other details :
Youth Plant II received such certification for the production of Lovastatin,
API.
(5)
Type of certification : GMP
Issuing authority : BPA of
DOH
Date of certification : 16 May,
2003
Other details :
Youth Plant III received such certification for the production of Cefaclor and
Cephalexin, API
(6)
Type of certification : GMP
Issuing authority : BPA of
DOH
Date of certification : 19,
August, 2003
Other details :
Youth Plant I received such certification
for the production of API of Paclitaxel
(7)
Type of certification : GMP
Issuing authority : BPA of
DOH
Date of certification : 10
September, 2003
Other details :
Youth Plant I received such certification for the production of UBI HCV EIA in
Vitro Diagnostic Kits
(8)
Type of certification : Cephalexin capsule approval
Issuing authority : FDA
ANDA
Date of certification : March
2005
(9)
Type of certification : Cephalexin capsule approval
Issuing authority : FDA
ANDA
Date of certification : March
2005
*Exhibition Participation*
===================
Exhibition fair : MEDIPHAR
TAIPEI - Int'l Show on Medical Equipment, Pharmaceuticals & Bio-Technology
Dates attended : 7-10 November, 2003
Location : Taipei
World Trade Center (TWTC)
*Associations*
============
Member of the following associations:
Local
-------
- Chinese Pharmaceutical Manufacture & Development Association
(CPMDA)
- Science & Technology Library Network, ROC (SATLINE)
- PDA Taiwan Chapter
- Rolled Release Association
- Chinese Chemical Society
- Pharmaceutical Society of China Taiwan
International
-----------------
- American Chemical Society
- American Association of the Advancement of Science
- PDA
- American Pharmacy Association
- American Association of Pharmaceutical Studies
*Competitors*
===========
The following locally based companies supply similar range of products:
- BRISTOL-MYERS SQUIBB (TAIWAN) LTD
- CENTURY CHEMICAL & PHARMACEUTICAL CO LTD
- CHAING CHOEN PHARMACEUTICAL CO LTD
- CHIAI SHOU CHEMICAL & PHARMACY CO LTD
- CHUNG I PHARMACEUTICAL CO LTD
- ROCHE PRODUCTS LTD
- TAIWAN BIOTECH CO LTD
- GIDDI PHARMA CO LTD
*Domestic Customers*
==================
Maintains over 11,000 customers which include:
- Hospitals and clinics
- Drugstores
- Animal breeding farms
- Veterinarians' surgeries
*Local Distribution Network*
=======================
An estimated 94% of the annual turnover is attributed to local sales
through sales representatives and retailers.
Sales breakdown as per distribution channel:
Distribution channel
Percentage (%)
----------------------------
---------------------
Clinics 41.00
Hospital 23.00
Drugstores 19.00
Breeding farms 10.00
Others 7.00
*Export Markets*
==============
An estimated 6% of the annual turnover is attributed to export.
*International Trade Ranking*
=======================
The firm has been ranked among Taiwan's Top Importers/Exporters based on
the standard measured by the Board of Foreign Trade (BOFT)
Details of rank are as follows:
Year Rank
------ ----------
1997 1,409
2004 1,951
2005 1,659
2006 2,175
*LOCAL BRANCHES & MANAGEMENT*
=================================
Branch : YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD - TAIPEI CITY
Branch Address : 12Fl, 181 Min Chuan East Rd Section 3 Chungshan Dist,
Taipei City, 104
Branch Tel : [+886] 2-27187272
Branch Employees : 19
Branch : YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD - KAOHSIUNG HSIEN
Branch Address : 73 Chiu Chang Rd Niaosung Hsiang, Kaohsiung Hsien 833
Branch Tel : [+886] 7-3701200
Branch Fax : [+886] 7-3701821
Branch Employees : 20
Branch : YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD (YOUTH FERMENTATION
& SPECIALITY CHEMICALS FACTORIES)
Branch Address : 29 Kung 6th Rd Youth Industrial Dist Tachia Chen,
Taichung Hsien 437
Branch Tel : [+886] 4-26818209
Branch Employees : 50
Branch : YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD (YOUTH ANTIBIOTICS
FACTORY)
Branch Address : 26 Kung 6th Rd Youth Industrial Dist Tachia Chen,
Taichung Hsien 437
Branch Tel : [+886] 4-26818209
Branch Fax : [+886] 4-26875100
Branch Employees : 50
Branch : YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD - TAICHUNG HSIEN
Branch Address : 9 Kung 7th Rd Youth Industrial Dist Tachia Chen,
Taichung Hsien 437
Branch Employees : 50
Branch : YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD - TAICHUNG HSIEN
Branch Address : 12-1 Kung 10th Rd Youth Industrial Dist Tachia Chen,
Taichung Hsien 437
Branch Tel : [+886] 4-6818209
Branch Fax : [+886] 4-6869418
Branch Employees : 50
*(Subsidiaries , Joint-ventures & Affiliates)
===============================
Company Name : ANGEL ASSOCIATES (TAIWAN) INC
Address : 8Fl, 435 Rui-Guang Rd Neihu Dist Taipei City 114 Taiwan
Country : Taiwan
Relationship : Subsidiary
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : BIOTRUST INT'L CORP
Address : 1Fl, 30, Alley 78, Chienkuo North Rd Section 1 Chungshan Dist
Taipei City 104 Taiwan
Country : Taiwan
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : CARLSBAD PHARMACEUTICALS INC
Address : 5923 Balfour Court Carlsbad 92008 California USA
Country : USA
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : CARLSBAD TECHNOLOGY INC
Address : 5923 Balfour Court Carlsbad 92008 California USA
Country : USA
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : GLOBECARE TRADING(SHANGHAI) CO LTD
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Telecommunications
Company Name : HSTI CO
Country : Japan
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Professional Services
Company Name : KUMPULAN YSP (M) SDN BHD
Address : Taman Tun Dr Ismail 18 Jalan Wan Kadir Kuala Lumpur 60000
Pahang Malaysia
Country : Malaysia
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : MYANMAR YUNG SHIN PHARMA LTD
Address : 91 Kyun Shwe Myang St Thuwunna Thingangyun Yangon 11072
Myanmar
Country : Myanmar
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : RESIDENT REPRESENTATIVE OFFICE OF YSP INDUSTRIES
(MALAYSIA) SDN BHD
Country : Vietnam
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Professional Services
Company Name : SHANGHAI YUNG ZIP PHARMACEUTICAL TRADING CO LTD
Address : Rm 1524 Waigaoqiao Free Trade Zone - Tomson Int'l Trade Bldg 1
Jilong Rd Shanghai 200137 China
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Materials Handling
Company Name : YSP CAMBODIA PTE LTD
Address : 799 Kampuchea Krom St 128 Phnom Penh Cambodia
Country : Cambodia
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : YSP INDUSTRIES (M) SDN BHD
Address : Taman Tun Dr Ismail 18-20 Jalan Wan Kadir Kuala Lumpur 60000
Pahang Malaysia
Country : Malaysia
Relationship : Subsidiary
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : YSP INT'L CO LTD
Address : 30 Decastro St Road Town Tortola Virgin Islands (British)
Country : Virgin Islands (British)
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Financial Services - General
Company Name : YSP OVERSEA INVESTMENT CO LTD
Address : Road Town Tortola Virgin Islands (British)
Country : Virgin Islands (British)
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Financial Services - General
Company Name : YSP SEA INVESTMENT CO LTD
Address : 30 Decastro Rd Road Town Tortola Virgin Islands (British)
Country : Virgin Islands (British)
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Financial Services - General
Company Name : YSP SOUTHEAST ASIA HOLDING BHD
Address : Kawasan Perusahaan Bandar Baru Bangi Kajang 43650 Selangor
Malaysia
Country : Malaysia
Relationship : Affiliate
Legal Form : Public Listed Company
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : YSP USA INVESTMENT CO LTD
Address : 30 Decastro St Road Town Tortola Virgin Islands (British)
Country : Virgin Islands (British)
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Financial Services - General
Company Name : YUNG SHIN CHINA HOLDING CO LTD
Address : 2Fl Cayside Harbour Drive Georgetown Grand Cayman Cayman
Islands
Country : Cayman Islands
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Financial Services - General
Company Name : YUNG SHIN CO LTD
Address : B6 1Fl Shatin Industrial Centre 5-7 Yuen Shun Circuit Shatin
New Territories Hong Kong
Country : Hong Kong
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : YUNG SHIN PHARMACEUTICAL (S) PTE LTD
Address : Ruby Warehouse Complex 8 Kaki Bukit Rd 2 #02-26 417841
Singapore
Country : Singapore
Relationship : Subsidiary
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : YUNG SHIN PHARMACEUTICAL INDONESIA PT
Address : Jl Mangga Dua Raya E6 17 Jakarta Pusat Indonesia
Country : Indonesia
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : YUNG SHIN PHARMACEUTICAL INDUSTRIAL (KS) CO LTD
Address : Lujia He-Fong Industrial Dist 191 Jing Yang Rd Kunshan Dist
Suzhou 215331 Jiangsu China
Country : China
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
Company Name : YUNG SHIN PHILIPPINES INC
Address : 8822 Sampaloc St San Antonio Vill Makati 1203 NCR Philippines
Country : Philippines
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Trader
Industry : Medical Equipment & Pharmaceutical
Company Name : YUNG SHIN SOUTH EAST ASIA SDN BHD
Address : Taman Tun Dr Ismail 18 Jalan Wan Kadir Kuala Lumpur 60000
Pahang Malaysia
Country : Malaysia
Relationship : Affiliate
Legal Form : Private company with limited liability
Company Type : Service
Industry : Financial Services - General
Company Name : YUNG ZIP CHEMICAL INDUSTRY CO LTD
Address : Taichung You Shih Industrial Park 59 You Shih Rd Tachia Chen
437 Taichung Hsien Taiwan
Country : Taiwan
Relationship : Affiliate
Legal Form : Public Company
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
*Strategic Partners & Alliances*
========================
The R&D Division collaborates with the following institutions and
organizations:
- Industrial Development Bureau
- Ministry of Economic Affairs (MOEA)
- National Council
- Industrial Technology Research Institute (ITRI)
- Union Chemical Laboratory
- Chinese Pharmaceutical Manufacture & Development Association
(CPMDA)
- Union Chemical Laboratory
- ITRI Materials Research Laboratories
- ITRI Biomedical Engineering Center
- Food Industry Research & Development Institute (FIRDI)
- Animal Technology Research Institute, Taiwan
- Ching Hsing Medical & Cultural Foundation
- Pharmaceutical Industry Technology & Development Center (PITDC)
- Tze-Chiang Foundation of Science & Technology
- National Defense Education Research Foundation
- National Taiwan University
- China Medical College
- National Tsing Hua University
- National Chung Hsing University
- Chianan University of Pharmacy & Science
- Feng Chia University
- School of Pharmacy
- National Defense Medical Center
- MDS Pharma Service Pharmacology
- UNI-PRESIDENT ENTERPRISES CO LTD
*OVERSEAS AGENTS AND DISTRIBUTORS*
===================================
Agent : SALTERS-FISHER MEDICAL HOLDINGS LTD
Country of Origin : South Africa
PAYMENT RATING : 1 OBTAINED
SCORES : 86
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the
payment pattern of SC based upon our Payment Database, comments from suppliers
of SC, information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for LARGE
amounts depending on individual judgement experience.
*BANK DETAILS*
===============
Bank Name :
CHANG HWA COMMERCIAL BANK LTD
Branch :
Central Dist, Taichung City
Branch Address : 38
Tzu Yu Rd Section 2
SWIFT Code :
CCBCTWTP
Bank Name :
TAIWAN BUSINESS BANK
Branch :
Tatung Dist, Taipei City
Branch Address :
International Department 3Fl, 30 Ta Cheng St
SWIFT Code :
MBBTTWTP
Balance Sheet
Currency : NTD
Denomination : in Thousands
2006 2007
---------------- ----------------
Current Assets 2,354,763 2,503,707
Funds & long-term investments 1,355,918 1,462,437
Property
2,036,874 2,049,883
Other Assets 73,390 78,339
Current Liabilities (Before) 494,982 694,448
(After) 1,038,547 -
Long-term Liabilities 640 -
Other Liabilities 198,575 244,084
Common stock 2,537,362 2,537,362
Capital Reserve 451,237 453,677
Retained Earnings (Before) 2,119,764 2,129,675
(After) 1,576,199 -
Total Assets 5,831,517 6,106,690
Total Liabilities (Before) 699,005 943,340
(After)
1,242,570
-
Total Shareholder's Equity (Before) 5,132,512
5,163,350
(After) 4,588,947 -
Income Statement
Currency : NTD
Denomination : in Thousands
2006 2007
---------------- ----------------
Operating revenue 2,900,525 3,128,157
Gross Profit 1,834,844 1,840,170
Operating Income 565,596 568,149
Non-operating income 205,158 201,599
Non-operating expense 21,176 40,751
Net Income 590,414 558,264
Earnings (losses) per share
(After)
2.33 2.2
*Financial Ratio*
=============
2006 2007
----------------
----------------
Ratio of liabilities to Assets % 12.00 15.00
Ratio of long-term capital to
fixed Assets%
252.00 252.00
Current ratio% 476.00 361.00
Quick ratio% 311.00 214.00
Interest coverage 852.00 2,323.00
Turnover of receivable (times) 3 3.43
Average collection period of
receivable 110.00 107.00
Turnover of inventories (times) 1.35 1.39
Average days of sales 271.00 263.00
Turnover of fixed assets (times)
1.42 1.53
Turnover of total assets (times) 0.50 0.51
Return on total assets% 10.13 9.14
Return on shareholder's Equity% 11.50 10.81
Operating Income 22 22
Net Income before tax 30.00 29.00
Profit margin% 20.00 18.00
Retroactive 2.33 2.20
Cash flows ratio% 86 110.00
Cash flows adequacy% 96.00 85.00
Cash reinvestment ratio% 1.00 3.00
Degree of operating leverage 5.67 6.18
Degree of financial leverage 1.00 1
*Financial Summary (Currency: U.S. $'s)
==============================
Year Sales Assets Net Income
1999 $76,259,062.50 $176,155,718.75 $9,543,593.75
2000 $76,113,437.01 $165,061,990.67 $9,072,970.45
2001 $72,815,728.38 $153,096,517.70 $11,115,438.19
2002 $68,004,052.89 $151,867,289.45 $13,005,202.64
2003 $70,368,194.93 $154,946,943.48 $14,407,727.80
2004 $84,490,165.41 $175,078,887.22 $21,720,932.33
2005 $93,589,541.86 $184,039,778.83 $14,870,963.67
2006 $87,682,134.22 $176,285,278.11 $17,848,065.30
2007 $94,392,184.67 $184,269,462.88 $16,845,624.62
*Int´l Trade Activity (Currency: U.S. $'s)
==============================
Year Imports Exports Total
2000 $8,796,772.01 $3,918,602.02 $12,715,374.03
2001 $10,541,923.97
$4,927,493.91 $15,469,417.88
2002 $7,646,216.47 $3,885,937.60 $11,532,154.07
2004 n/a $3,379,248.12
$3,379,248.12
2005 $3,743,532.39 n/a $3,743,532.39
2006 $11,337,012.00
$5,266,422.01 $16,603,434.01
2007 $13,000,000.00
$6,000,000.00 $19,000,000.00
SC is considered large-sized in its line with a long development history.
The above credit amount appears to be within SC’s capacities.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Manufacturing 2000 Food
and Kindred Products
Manufacturing 2800 Chemicals
and Allied Products
Manufacturing 2833 Medicinals
and botanicals
Manufacturing 2834 Pharmaceutical
preparations
Manufacturing 2835 Prepared
diagnostic substances
Manufacturing 2844 Toilet
preparations
Manufacturing 2899 Chemical
preparations,
Trading 2800 Chemicals
and Allied Products
Trading 2833 Medicinals
and botanicals
Trading 2834 Pharmaceutical
preparations
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Exporting 3003400000 Medicaments containing alkaloids or derivatives thereof but not
containing hormones or other products of heading 2937 or antibiotics
Exporting 3003900000 Other medicaments (excluding goods of heading 3002, 3005 or
3006) consisting of two or more constituents which have been mixed together etc
Importing 1302190000 Vegetable saps and extracts
Importing 1702190000 Lactose in solid form and lactose syrup
Importing 2101200000 Tea or mate extracts, essences and concentrates and
preparations with a basis of these extracts/essences/concentrates or with a
basis of tea or mate
Importing 2818300000 Aluminum hydroxide
Importing 2915600000 Butyric acid, valeric acid, their salts and esters
Importing 2922 Oxygen-function
amino-compounds
Importing 2924 Carboxyamide-function
comp; amide-function com etc
Importing 2925 Carboxyimide-function
comp; imine-function com etc
DETAILED PRODUCT
CLASSIFICATION & ACTIVITY
Activity Product/Service Description
Manufacturer Lecithin
Manufacturer Cephradine
Manufacturer Medicaments
Manufacturer FC tablets
Manufacturer Veterinary
products
Manufacturer Gastrointestinal
drug
Manufacturer Gemfibrozil
Manufacturer Simvastatin
Manufacturer Cefuroxime
Manufacturer Cefoperazone
INTERNATIONAL
TRADE: ACTIVITY & MARKETS
Country / Region Main Trading Activity
Asia / Pacific Exporting,Importing
Europe Exporting,Importing
Middle-East Importing
North America Exporting
Australia Importing
Austria Importing
Belgium Importing
China Exporting,Importing
France Importing
Germany Exporting,Importing
Hong Kong Exporting
India Importing
Israel Importing
Italy Importing
Japan Exporting,Importing
Malaysia Exporting
Mexico Importing
Oman Importing
Pakistan Exporting
Panama Exporting
Philippines Exporting
Singapore Exporting
Slovenia Importing
South Africa Exporting
South Korea Importing
Spain Importing
Switzerland Exporting,Importing
Thailand Exporting,Importing
Turkey Importing
USA Exporting,Importing
United Kingdom Importing
Vietnam Exporting
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.38 |
|
UK Pound |
1 |
Rs.81.34 |
|
Euro |
1 |
Rs.64.55 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)